WASHINGTON — Novavax’s closely watched COVID-19 vaccine is on track for full ... vaccine safety. With full FDA approval, Novavax would have permission to keep its shot on the ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full approval, sending the drugmaker's shares soaring and easing concerns around the ...